Reyes-Hernández KL, López-Cruz G, Romero-Feregrino R, Ávila-Correa A, Reyes-Hernández DP, Luévanos-Velázquez A, Reyes-Gómez U, Perea-Martínez A, Reyes-Hernández MU, Santamaría-Arza C

Language: Spanish
References: 35
Page: 72-81
PDF size: 639.59 Kb.

ABSTRACT

According to the World Health Organization (WHO), rotavirus represents the major cause of serious illness in the world. In Mexico, an incidence of Rotavirus infection of 4.5 infections per 100 children per month is reported. Objetive: To report the series of cases of newborns with community acquisition of rotavirus gastroenteritis was made a prospective, descriptive, observational study of children under 30 days in the period from November 1, 2008 to August 30, 2016, the common feature among them was that they had a probable clinical picture of viral gastroenteritis and confirmation of positive rotavirus in feces, by the technique of agglutination of particles in latex (rotaquick) were excluded those that had another etiology.
Thirty-two cases were analyzed. Their average age was 23 days, 19 were male, 24 were eutrophic, exclusively fed with breast milk 18, in mixed form 6. They had with vomiting 18, diarrhea 23, colic in 29, abdominal distension 31, in important form 8, tenesmus 9, mild disappearance 8, moderate 22 and severe 2. 18 had leukocytosis, 31 had relative lymphocytosis. They studied with isonatremia 24, hypernatremia 4, hyponatremia 4, hypokalemia 12 cases. The coprologo showed PH of 5, fats from +++ to +++ crosses in 31 cases, all had Rotavirus positive (rotaquick). They were hydrated orally with oral hydration therapy 28, with 2 treatment failures, hospitalized 6 cases with good evolution. Mortality was 0.3%.
The clinical picture of rotavirus in the newborn is different from that seen in infants. Abdominal distention and colic followed by vomiting and diarrhea predominate. Feeding with breast milk is a protective factor of mortality.

REFERENCES

1. Word Health Organization. Estimated rotavirus deaths for children under 5 years of age: 2013, 215 000. http:// www.who.int/immunization/monitoring_surveillance/ burden/estimates/rotavirus/en/

2. World Health Organization. Global. Plan of Action for Children’s Health and the Environment (2010-2015). 2011; 1-13.

3. Vesta R, et al. Effect of Rotavirus Vaccination on Death from Childhood Diarrhea in Mexico. N Engl J Med. 2010; 362: 299-305.

4. Herrera BI. Diarrea en el recién nacido. En: Romero CR, Herrera BI. Síndrome diarréico infeccioso. 1a ed. México: Editorial Médica Panamericana; 2002: 437-455.

5. Prelog M, Gorth P, Zwazl I, et al. Universal mass vaccination against rotavirus: Indirect effects on rotavirus infections in neonates and unvaccinated young infants not eligible for vaccination. JID. 2016; 214: 546-555.

6. García RC, Larre N, Pastene H, Gutiérrez L, Vaccaro J, Sciarrota JA, et al. Características epidemiológicas y clínicas de las gastroenteritis agudas según su etiología por rotavirus u otra en niños menores de 5 años atendidos en una institución privada de la Ciudad Autónoma de Buenos Aires (en línea). Arch Argent Pediatr. 2013 (junio).

7. Reyna FJ, Sánchez UE, Esteves JA, Hernández HL, Richardson V. Diarrheal disease caused by rotavirus in epidemic outbreaks. Rev Soc Bol Ped. 2012; 51 (3): 168- 175.

8. Sarkar R, Gladstone BP, Warier JP, et al. Rotavirus and other diarrheal disease in a birth cohort from southern Indian community. Indian Pediatrics. 2016; 53 (15): 583- 588.

9. Castell RE, Reyes HD, Reyes GU, Reyes HU, Ávila CF, Reyes HK, et al. Gastroenteritis por rotavirus en el recién nacido, reporte preliminar de 12 casos adquiridos en la comunidad. Rev Enf Inf Microbiol. 2012; 32 (3): 108-113.

10. Prevención, Diagnóstico y Tratamiento de la Enfermedad Diarreica Aguda en niños de dos meses a cinco años en el primero y segundo nivel de atención, México: Secretaría de Salud, 2008.

11. Reyes GU, Pérez GJ, López CG, Sánchez CHN, Toledo RM. Valor del coprológico en la diarrea aguda en niños menores de 5 años. Rev Mex Puer Ped. 2004; 1 (64): 102-108.

12. Organización Mundial de la Salud. Centro de Prensa. Reducción de la mortalidad en la niñez. Descargado de: http://www.who.int/mediacentre/factsheets/fs178/es/

13. Velázquez JL. Alteraciones hidroelectrolíticas en Pediatría. 2ª edición. México: Editorial Prado; 2012: 151- 174.

14. Ruíz MA, Padilla R, Mohs E. Rotavirus en un servicio de neonatología, descripción de una epidemia. Rev Med Hosp Nal Niños Costa Rica. 1980; 2: 159-172.

15. Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009; 200 (1): S9-S15.

16. Wiegering V, Kaiser J, Tappe D, Weissbrich B, Morbach H, Girschick HJ. Gastroenteritis in childhood: a retrospective study of 650 hospitalized pediatric patients. Int J Infect Dis. 2011; 15 (6): 401-407.

17. Vega FL, Carbajal VA, Florentina GM, Romo G, Gamboa MJ. El vómito con indicador clínico de la diarrea por rotavirus. Bol Clin Hosp Inf Mex. 1985; 42 (3): 169-174.

18. Reyes GU, Ramírez PB, Reyes HU, Hernández LI, Reyes HD, Martínez RA. Gastroenteritis por rotavirus en lactantes previamente inmunizados. Rev Enf Infec Ped. 2019; 23 (89): 8-12.

19. Reyes HD, Reyes HK, Reyes GU, Pérez PO, Ángelo QM, Reyes HU. Comportamiento clínico de 70 casos de gastroenteritis por rotavirus en lactantes previamente inmunizados. Rev Mex Ped. 2014; 81(6): 214-217.

20. Cerbulo VA, Ortiz IF, Arredondo GJ. La respuesta inmune celular del neonato. Perinatol Reprod Hum. 2000; 14: 88-92.

21. Myers MD. Grow with us natal gastroenteritis. Rotavirus transmission and prevention. Rev Enf Inf. 2013; 19 (2): 1-4.

22. Reyes HK, Reyes GU, García OK, Hernández LI, Reyes HD, Cobon BJ. Ictericia tardía como manifestación secundaria a infección por rotavirus: reporte de caso. Rev Mex Ultrasonido. 2017;

23. García PJ, Montejo GS, Torres CA, de Arriba MM, Fernández VS, Rite GS, Rite et al. Enterocolitis necro sante asociada a infección por rotavirus. Act Ped Esp. 2009; 67 (2): 88-89.

24. Reyes HK, Reyes GU, López CG, Quero HA, Reyes HD, Sánchez CHN. Enfermedad Diarreica Aguda, conceptos básicos. Aten Prim. 2015; 1 (1): 13-18.

25. Ezcárraga VY, Reyes GU, Pérez MA, Reyes HU, Reyes HD, Reyes HK, et al. Neumonía lipoidea exógena neonatal por “cura para el empacho”, reporte de caso. Rev Sal Qroo. 2016; 9 (35): 24-27.

26. Vila J, Álvarez-Martínez M, Brusa J, Castillo J. Diagnóstico microbiológico de las infecciones gastrointestinales. Enferm Infecc-Microbiol Clin. 2009; 27 (7): 406- 411.

27. Poomima D, Velázquez FR, Gutiérrez-Escalona AL, Luddert JE. Evaluation of the second generation of a commercial latex agglutination test for the detection of rotavirus antigens in fecal samples. Jour Clin Virol. 2013; 57 (1): 88-90.

28. Buesa J, Reza J, Villanueva A, Prat J. Evaluation of reverse transcription and polymerase chain reaction (RT/ PCR) for the detection of rotaviruses: Applications of the assay. Resea Virol. 1996; 147: 353-361.

29. Pang XL, Lee B, Boroumand N, Leblanc B, Preiksaitis JK, Ip CY. Increased detection of rotavirus using a real time reverse transcription polymerase chain reaction (RT-PCR) assay in stool specimens from children with diarrhea. J Med Virol. 2004; 72: 496-501.

30. Reyes GU, Pérez GJ, López CG, Sánchez CHN, Toledo RM. Valor del coprológico en la diarrea aguda en niños menores de 5 años. Rev Mex Puer Ped. 2004; 1 (64): 102-108.

31. Hernández OH, Aparicio SG, Lucas RE, Castañeda NJ, López CC, Díaz JV, et al. Rotavirus en la Unidad de Cuidados Intermedios Neonatales. Acta Pediatr Mex. 2014; 35 (5): versión On-line ISSN 2395-8235 versión impresa ISSN 0186-2391.

32. Uberos FJ. Vacunación frente a rotavirus en prematuros (en línea). URL disponible en http://ibvacunas.com/ wp-content/uploads/rotavirus_prematuros.pdf

33. Omenaca F, Sarlangue J, Szenborn L, Nogueira M, Suryakiran PV, Smolenov IV, et al. Safety, reactogenicity and immunogenicity of the human rotavirus vaccine in preterm European Infants: a randomized phase IIIb study. Pediatr Infect Dis J. 2012; 31 (5): 487-493.

34. Trall S, Muñeca MK, Nhan C, González M, Perreault T, Lamer P, Quach C. Evaluación de la pentavalente contra el rotavirus, vacunación en las unidades de cuidados intensivos neonatales. Vacuna. 2015; 33 (39): 5095-5102.

35. Norma Oficial Mexicana NOM-036-SSA2-2012, Prevención y control de enfermedades. Aplicación de vacunas, toxoides, faboterápicos (sueros) e inmunoglobulinas en el humano.